Carlos E. Figueroa Castro, MD, MS (BMI), FACP

Associate Professor

view physician profile

Locations

Froedtert West Bend Hospital
Pleasant Valley Health Center
Infectious Disease Clinic - Sargeant Health Center

Specialties

Infectious Disease

Languages

English, Spanish

Infectious Disease Clinic

(414) 805-6444

Pleasant Valley Health Center

(262) 836-7300

Education

MD - Doctor of Medicine
MS (BMI)
FACP - Fellow of the American College of Physicians

Biography

Dr. Figueroa Castro joined the Department of Medicine, Division of Infectious Diseases, at the Medical College of Wisconsin in December 2013. He received his medical degree from Universidad El Bosque in Bogota, Colombia in 1998. He completed his residency in internal medicine at the Medical College of Wisconsin in Milwaukee in 2006, and then completed fellowship in infectious diseases at Creighton University School of Medicine in Omaha, Nebraska in 2008. Dr. Figueroa Castro’s clinical practice includes the care of adults with a multitude of infectious conditions, including but not limited to skin infections, endocarditis, osteomyelitis, prosthetic joint infections, and atypical mycobacterial infections. He provides HIV care including pre-exposure prophylaxis (PrEP), post-exposure prophylaxis (PEP) and HIV therapy at Froedtert West Bend Hospital. He is the medical director for infection prevention of Froedtert Community Hospitals (Froedtert Menomonee Falls Hospital, Froedtert West Bend Hospital).

Research Interests

Dr. Figueroa Castro’s academic interests include clinical trials for the treatment of atypical mycobacterial infections, infection prevention, and biomedical informatics including the use of large datasets extracted from electronic medical records. His research activities have included the use of free and open-source software and cloud-based geographic information system tools for the study of Clostridioides difficile epidemiology in Southeastern Wisconsin, and multidisciplinary research on the impact of COVID-19 infection in various population of interest by analyzing data from the National COVID Cohort Collaborative (N3C).

Risk of Early Postoperative Cardiovascular and Cerebrovascular Complication in Patients with Preoperative COVID-19 Undergoing Cancer Surgery.

(SenthilKumar G, Verhagen NB, Nimmer K, Yang X, Figueroa Castro CE, Szabo A, Taylor BW, Wainaina N, Gould JC, Kothari AN, N3C Consortium.) J Am Coll Surg. 2024 Jun 01;238(6):1085-1097 PMID: 38348959 PMCID: PMC11330174 SCOPUS ID: 2-s2.0-85193311002 02/13/2024
Blood and marrow transplant within 4 weeks of SARS-CoV-2 infection is associated with increased risk of mortality: a National COVID Cohort Collaborative (N3C) Study.

(Mohan M, Kothari A, Verhagen N, Shreenivas A, Radhakrishnan SV, Dhakal B, Figueroa-Castro C, Chhabra S, Janz S, Pasquini M, Hamadani M, Szabo A, D'Souza A, N3C consortium.) Bone Marrow Transplant. 2024 Jan;59(1):121-124 PMID: 37803198 SCOPUS ID: 2-s2.0-85173730029 10/07/2023
Severity of Prior Coronavirus Disease 2019 is Associated With Postoperative Outcomes After Major Inpatient Surgery.

(Verhagen NB, SenthilKumar G, Jaraczewski T, Koerber NK, Merrill JR, Flitcroft MA, Szabo A, Banerjee A, Yang X, Taylor BW, Figueroa Castro CE, Yen TWF, Clarke CN, Lauer K, Pfeifer KJ, Gould JC, Kothari AN, N3C Consortium.) Ann Surg. 2023 Nov 01;278(5):e949-e956 PMID: 37476995 PMCID: PMC10659141 SCOPUS ID: 2-s2.0-85173563272 07/21/2023
Preoperative SARS-CoV-2 infection increases risk of early postoperative cardiovascular complications following noncardiac surgery.

(SenthilKumar G, Verhagen NB, Sheriff SA, Yang X, Figueroa Castro CE, Szabo A, Taylor BW, Wainaina N, Lauer K, Gould JC, Kothari AN, N3C Consortium.) Am J Physiol Heart Circ Physiol. 2023 Jun 01;324(6):H721-H731 PMID: 36930659 PMCID: PMC10151044 SCOPUS ID: 2-s2.0-85153899506 03/18/2023
Severity of Prior COVID-19 Infection is Associated with Postoperative Outcomes Following Major Inpatient Surgery.

(Verhagen NB, SenthilKumar G, Jaraczewski T, Koerber NK, Merrill JR, Flitcroft MA, Szabo A, Banerjee A, Yang X, Taylor BW, Castro CEF, Yen TWF, Clarke CN, Lauer K, Pfeifer KJ, Gould JC, Kothari AN.) medRxiv. 2023 Apr 17 PMID: 37131614 PMCID: PMC10153306 05/03/2023
Clinical Characterization and Prediction of Clinical Severity of SARS-CoV-2 Infection Among US Adults Using Data From the US National COVID Cohort Collaborative.

(Bennett TD, Moffitt RA, Hajagos JG, Amor B, Anand A, Bissell MM, Bradwell KR, Bremer C, Byrd JB, Denham A, DeWitt PE, Gabriel D, Garibaldi BT, Girvin AT, Guinney J, Hill EL, Hong SS, Jimenez H, Kavuluru R, Kostka K, Lehmann HP, Levitt E, Mallipattu SK, Manna A, McMurry JA, Morris M, Muschelli J, Neumann AJ, Palchuk MB, Pfaff ER, Qian Z, Qureshi N, Russell S, Spratt H, Walden A, Williams AE, Wooldridge JT, Yoo YJ, Zhang XT, Zhu RL, Austin CP, Saltz JH, Gersing KR, Haendel MA, Chute CG, National COVID Cohort Collaborative (N3C) Consortium.) JAMA Netw Open. 2021 Jul 01;4(7):e2116901 PMID: 34255046 PMCID: PMC8278272 07/14/2021
1409. Pulmonary Non-tuberculous Mycobacterium Infection (PNTMI) and COVID-19: Characterization of the National COVID Collaborative Cohort (N3C).

(Figueroa Castro CE, Hersh W.) Open Forum Infectious Diseases. Open Forum Infect Dis. 2021 November:8(Supp 1), Pages S788–S789 12/04/2021
Immediate impact of healthcare-facility-onset Clostridium difficile laboratory-identified events reporting methodology change on standardized infection ratios.

(Figueroa Castro CE, Palen L, Johnson C, Graham MB, Letzer D, Ledeboer N, Buchan B, Block T, Seliger H, Singh S, Behrens E, Huerta S, Munoz-Price LS.) Infect Control Hosp Epidemiol. 2018 Dec;39(12):1484-1486 PMID: 30348236 SCOPUS ID: 2-s2.0-85055537816 10/24/2018
Elizabethkingia anophelis: Clinical Experience of an Academic Health System in Southeastern Wisconsin.

(Figueroa Castro CE, Johnson C, Williams M, VanDerSlik A, Graham MB, Letzer D, Ledeboer N, Buchan BW, Block T, Borlaug G, Munoz-Price LS.) Open Forum Infect Dis. 2017;4(4):ofx251 PMID: 29308406 PMCID: PMC5751080 SCOPUS ID: 2-s2.0-85056804311 01/09/2018
Use of 16s rRNA gene sequencing to identify a case of Pediococcus parvulus bacteremia in a patient with metastatic testicular cancer

(Figueroa Castro CE, Knezetic JA, Cavalieri SJ.) Laboratory Medicine. February 2010;41(2):93-95 SCOPUS ID: 2-s2.0-77951941937 02/01/2010
Use of 16s rRNA Gene Sequencing to Identify a Case of Pediococcus parvulus Bacteremia in a Patient with Metastatic Testicular Cancer

(Figueroa Castro CE, Knezetic JA, Cavalieri SJ.) LabMedicine. LabMedicine 2010;41:93-95 09/09/2009
Citrobacter koseri Endocarditis in a Patient Undergoing Hemodialysis: Case Report and Review of the Literature

(Figueroa Castro CE, Smith PW.) Infectious Diseases in Clinical Practice. Infect Dis Clin Practice 2009;17:198-200 05/01/2009